New approaches of green silver nanoparticles for cancer and biomedical applications: a review
Puja Kumari , Khushi Quadri , Renu Kadian , Saloni Mishra , Aafrin Waziri , Kaustub Jumle , Kumar Sambhav Verma , Md Sabir Alam
Exploration of Targeted Anti-tumor Therapy ›› 2025, Vol. 6 ›› Issue (1) : 1002341
The green synthesis of silver nanoparticles (AgNPs) has recently gained prominence as a sustainable and eco-friendly alternative to conventional physical and chemical methods. Utilizing biological entities such as plant extracts, bacteria, fungi, and biomolecules, the method acts by both reducing and stabilizing mechanisms. It does not use any harmful chemical substances, thus proving to be eco-friendly. Green-synthesized AgNPs exhibit enhanced biocompatibility, stability, and targeted delivery of the drug due to the use of naturally derived surface capping agents. These unique characteristics allow selective interference with cancer cells. The mechanism involved is the generation of reactive oxygen species (ROS), the induction of apoptosis, DNA damage, and cell cycle arrest. Green AgNPs also possess broad-spectrum antimicrobial, catalytic, antiparasitic, and anti-inflammatory properties, supporting the fact that they can be utilised in biomedical fields such as drug delivery, bioimaging, biosensing, tissue engineering, and regenerative medicine. Recent advancements have focused on controlling NP size, shape, and surface functionality to maximize efficacy while simultaneously minimizing cytotoxicity. This review provides a comprehensive analysis of the latest green synthesis strategies, their characterizations, and the molecular mechanisms by which they exert anticancer effects. Recent patents highlight the clinical potential of AgNPs in cancer therapy. US Patent 12201650 (2025) describes green synthesis using Caralluma sinaica, while other patents (WO2007001453, US7462753) outline adaptable biomedical formulations. Studies on biogenic AgNPs also show significant tumor inhibition and selective cytotoxicity against cancer cells. Furthermore, the article discusses current biomedical applications and critically evaluates the limitations, such as reproducibility, toxicity concerns, and scalability for clinical translation. Addressing these challenges is essential for the integration of green AgNPs into mainstream cancer therapeutics. The convergence of nanotechnology and biologically derived synthesis opens promising avenues for the development of safe, effective, and environmentally sustainable medical innovations.
green synthesis / silver nanoparticles / cancer therapy / biomedical applications / nanotechnology
| [1] |
Shahzadi S, Fatima S, |
| [2] |
|
| [3] |
|
| [4] |
Ahmad A, Haneef M, Ahmad N, Kamal A, Jaswani S, |
| [5] |
Rupanshi, |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
Bhushan B. Introduction to Nanotechnology. In: the Author, editor. Springer Handbook of Nanotechnology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2017. pp. 1-19. |
| [17] |
Roco MC. Towards a US National Nanotechnology Initiative. J Nanopart Res. 1999; 1: 435-8. |
| [18] |
|
| [19] |
Bhushan B. Introduction to Nanotechnology: History, Status, and Importance of Nanoscience and Nanotechnology Education. In: Winkelmann K, Bhushan B, editors. Global Perspectives of Nanoscience and Engineering Education. Springer, Cham; 2016. pp. 1-31. |
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
Konop M, Damps T, Misicka A, Rudnicka L. Certain Aspects of Silver and Silver Nanoparticles in Wound Care: A Minireview. J Nanomater. 2016; 2016: 7614753. |
| [24] |
|
| [25] |
|
| [26] |
Alexander JW. History of the medical use of silver. Surg Infect (Larchmt). 2009; 10: 289-92. |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
White RJ. An historical overview of the use of silver in wound management. Br J Nurs. 2001; 10: S3-8. |
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
Lansdown ABG. Silver in Healthcare: Its Antimicrobial Efficacy and Safety in Use. 1st ed. Royal Society of Chemistry; 2010. |
| [52] |
|
| [53] |
Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 2000; 26: 131-8. |
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
Huang H, |
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
Ahmad A, Senapati S, Khan MI, Kumar R, |
| [91] |
|
| [92] |
Mukherjee P, Ahmad A, Mandal D, Senapati S, |
| [93] |
Kumar P, Singh P, Kumari K, Mozumdar S, |
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
de Oliveira Bianchi JR, Menezes de Souza S, Boggione Santos IJ. Post-Harvest Application of Tara Gum Coating Incorporated With Silver Nanoparticles for Preservation of Banana. Biointerface Res Appl Chem. 2023; 13: 81. |
| [132] |
|
| [133] |
|
| [134] |
Sepeur S. Nanotechnology: Technical Basics and Applications. Vincentz Network; 2008. |
| [135] |
|
| [136] |
Poinern GEJ. A Laboratory Course in Nanoscience and Nanotechnology. 1st ed. Boca Raton: CRC Press; 2015. |
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
Giannini C, Ladisa M, Altamura D, Siliqi D, Sibillano T, De Caro L. X-ray Diffraction: A Powerful Technique for the Multiple-Length-Scale Structural Analysis of Nanomaterials. Crystals. 2016; 6: 87. |
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
Kar B, Bose A, Roy S, Chakraborty P, Chakraborty S, |
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
Binnig G, |
| [165] |
|
| [166] |
|
| [167] |
|
| [168] |
|
| [169] |
|
| [170] |
|
| [171] |
|
| [172] |
Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010; 49: 6288-308. |
| [173] |
|
| [174] |
Ulbrich K, Holá K, Šubr V, Bakandritsos A, Tuček J, |
| [175] |
|
| [176] |
|
| [177] |
|
| [178] |
|
| [179] |
|
| [180] |
Yao Y, Saw PE, Nie Y, Wong PP, Jiang L, Ye X, |
| [181] |
|
| [182] |
|
| [183] |
|
| [184] |
|
| [185] |
|
| [186] |
|
| [187] |
|
| [188] |
|
| [189] |
Sarkar S, |
| [190] |
|
| [191] |
|
| [192] |
|
| [193] |
|
| [194] |
Hemlata, |
| [195] |
|
| [196] |
|
| [197] |
|
| [198] |
|
| [199] |
|
| [200] |
|
| [201] |
|
| [202] |
|
| [203] |
|
| [204] |
|
| [205] |
|
| [206] |
|
| [207] |
|
| [208] |
|
| [209] |
|
| [210] |
|
| [211] |
|
| [212] |
|
| [213] |
|
| [214] |
|
| [215] |
|
| [216] |
|
| [217] |
|
| [218] |
|
| [219] |
|
| [220] |
|
| [221] |
|
| [222] |
|
| [223] |
|
| [224] |
Namita, Arti, |
| [225] |
|
| [226] |
|
| [227] |
|
| [228] |
|
| [229] |
|
| [230] |
|
| [231] |
|
| [232] |
|
| [233] |
Sethi S, Saruchi, Medha, Thakur S, |
| [234] |
|
| [235] |
Wang H, Li G, Jia L, Wang G, |
| [236] |
|
| [237] |
|
/
| 〈 |
|
〉 |